These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24471499)

  • 1. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.
    Pan S; Chen R; Tamura Y; Crispin DA; Lai LA; May DH; McIntosh MW; Goodlett DR; Brentnall TA
    J Proteome Res; 2014 Mar; 13(3):1293-306. PubMed ID: 24471499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoproteins and glycoproteomics in pancreatic cancer.
    Pan S; Brentnall TA; Chen R
    World J Gastroenterol; 2016 Nov; 22(42):9288-9299. PubMed ID: 27895417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration.
    Chen Y; Zheng B; Robbins DH; Lewin DN; Mikhitarian K; Graham A; Rumpp L; Glenn T; Gillanders WE; Cole DJ; Lu X; Hoffman BJ; Mitas M
    Int J Cancer; 2007 Apr; 120(7):1511-7. PubMed ID: 17192896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.
    Nigjeh EN; Chen R; Allen-Tamura Y; Brand RE; Brentnall TA; Pan S
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28627758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness.
    Ganguly K; Krishn SR; Rachagani S; Jahan R; Shah A; Nallasamy P; Rauth S; Atri P; Cox JL; Pothuraju R; Smith LM; Ayala S; Evans C; Ponnusamy MP; Kumar S; Kaur S; Batra SK
    Cancer Res; 2021 Jan; 81(1):91-102. PubMed ID: 33127746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer.
    Yamazoe S; Tanaka H; Iwauchi T; Yoshii M; Ito G; Amano R; Yamada N; Sawada T; Ohira M; Hirakawa K
    Pancreas; 2011 Aug; 40(6):896-904. PubMed ID: 21697763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.
    Mirus JE; Zhang Y; Hollingsworth MA; Solan JL; Lampe PD; Hingorani SR
    Mol Cell Proteomics; 2014 Dec; 13(12):3484-96. PubMed ID: 25225358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC).
    Zińczuk J; Zaręba K; Romaniuk W; Kamińska D; Nizioł M; Baszun M; Kędra B; Guzińska-Ustymowicz K; Pryczynicz A
    Int J Med Sci; 2019; 16(4):583-592. PubMed ID: 31171910
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma.
    Fukushima N; Koopmann J; Sato N; Prasad N; Carvalho R; Leach SD; Hruban RH; Goggins M
    Mod Pathol; 2005 Jun; 18(6):779-87. PubMed ID: 15791284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma.
    Kantheti HS; Hale MA; Pal Choudhuri S; Huang H; Wang XD; Zolghadri Y; Innamorati G; Manikonda SPR; Reddy N; Reddy S; Kollipara RK; Lumani V; Girard L; Bezrukov Y; Demenkov P; MacDonald RJ; Brekken RA; Yu Y; Wilkie TM
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate data analysis for the detection of human alpha-acid glycoprotein aberrant glycosylation in pancreatic ductal adenocarcinoma.
    Mancera-Arteu M; Giménez E; Balmaña M; Barrabés S; Albiol-Quer M; Fort E; Peracaula R; Sanz-Nebot V
    J Proteomics; 2019 Mar; 195():76-87. PubMed ID: 30641231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma.
    Kumazoe M; Takai M; Hiroi S; Takeuchi C; Kadomatsu M; Nojiri T; Onda H; Bae J; Huang Y; Takamatsu K; Yamashita S; Kangawa K; Tachibana H
    J Biol Chem; 2017 Jun; 292(26):10813-10823. PubMed ID: 28507102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.
    Kubuschok B; Xie X; Jesnowski R; Preuss KD; Romeike BF; Neumann F; Regitz E; Pistorius G; Schilling M; Scheunemann P; Izbicki JR; Löhr JM; Pfreundschuh M
    Int J Cancer; 2004 Apr; 109(4):568-75. PubMed ID: 14991579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of pancreatitis-associated protein (PAP) in human pancreatic ductal adenocarcinoma.
    Xie MJ; Motoo Y; Iovanna JL; Su SB; Ohtsubo K; Matsubara F; Sawabu N
    Dig Dis Sci; 2003 Mar; 48(3):459-64. PubMed ID: 12757156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the ZEB2 gene in pancreatic stromal cells in pancreatic ductal adenocarcinoma, pancreatitis, and normal state.
    Usova EV; Kopantseva MR; Kostina MB; Van'kovich AN; Egorov VI; Kopantsev EP
    Dokl Biol Sci; 2013 Jan; 448():61-4. PubMed ID: 23479023
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
    Shen J; Person MD; Zhu J; Abbruzzese JL; Li D
    Cancer Res; 2004 Dec; 64(24):9018-26. PubMed ID: 15604267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer.
    Ohya A; Yamanoi K; Shimojo H; Fujii C; Nakayama J
    Cancer Sci; 2017 Sep; 108(9):1897-1902. PubMed ID: 28685935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
    Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.